CSF3 and hematologic disorder: It rapidly and reversibly mobilizes hematopoietic stem cells into the peripheral circulation and was first approved in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with hematological malignancies.